Continuation of Anti-TNF for IBD After 24 Weeks of Pregnancy Beneficial
Risk for maternal IBD relapse and prematurity reduced with continuation of anti-TNF after 24 weeks of pregnancy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.